Analysts Downgrade Immuneering Corporation Due to Concerns Over Efficacy of IMM1104
Question: Analysts have downgraded Immuneering Corporation (NASDAQ: IMRX) due to concerns over the efficacy of IMM-1-104 in solid tumor trials. ...
Tag: IMRX
Immuneering Shares Plunge as Trading Halted
Trading of Immuneering shares has come to a sudden stop today, March 14, 2024. This pause was caused by a ...
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
